12-88118527-ATT-AT

Variant summary

Our verdict is Pathogenic. The variant received 20 ACMG points: 20P and 0B. PVS1PS3PP5_Very_Strong

The NM_025114.4(CEP290):​c.1666delA​(p.Ile556PhefsTer17) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000161 in 1,502,300 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★★). ClinVar reports functional evidence for this variant: "SCV005375243: Well-established in-vitro or in-vivo functional studies supportive of a damaging effect on the gene or gene product PMID:29771326". Synonymous variant affecting the same amino acid position (i.e. I556I) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.

Frequency

Genomes: 𝑓 0.000053 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00017 ( 0 hom. )

Consequence

CEP290
NM_025114.4 frameshift

Scores

Not classified

Clinical Significance

Pathogenic criteria provided, multiple submitters, no conflicts P:18

Conservation

PhyloP100: 2.81

Publications

10 publications found
Variant links:
Genes affected
CEP290 (HGNC:29021): (centrosomal protein 290) This gene encodes a protein with 13 putative coiled-coil domains, a region with homology to SMC chromosome segregation ATPases, six KID motifs, three tropomyosin homology domains and an ATP/GTP binding site motif A. The protein is localized to the centrosome and cilia and has sites for N-glycosylation, tyrosine sulfation, phosphorylation, N-myristoylation, and amidation. Mutations in this gene have been associated with Joubert syndrome and nephronophthisis and the presence of antibodies against this protein is associated with several forms of cancer. [provided by RefSeq, Jul 2008]
CEP290 Gene-Disease associations (from GenCC):
  • CEP290-related ciliopathy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • Joubert syndrome 5
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • Bardet-Biedl syndrome 14
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • Leber congenital amaurosis 10
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • Leber congenital amaurosis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Bardet-Biedl syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Joubert syndrome with oculorenal defect
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Meckel syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Senior-Loken syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 20 ACMG points.

PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PS3
PS3 evidence extracted from ClinVar submissions: SCV005375243: Well-established in-vitro or in-vivo functional studies supportive of a damaging effect on the gene or gene product PMID: 29771326
PP5
Variant 12-88118527-AT-A is Pathogenic according to our data. Variant chr12-88118527-AT-A is described in ClinVar as Pathogenic. ClinVar VariationId is 217622.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_025114.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CEP290
NM_025114.4
MANE Select
c.1666delAp.Ile556PhefsTer17
frameshift
Exon 17 of 54NP_079390.3O15078

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CEP290
ENST00000552810.6
TSL:1 MANE Select
c.1666delAp.Ile556PhefsTer17
frameshift
Exon 17 of 54ENSP00000448012.1O15078
CEP290
ENST00000604024.5
TSL:1
c.832delAp.Ile278PhefsTer17
frameshift
Exon 8 of 20ENSP00000473863.1S4R322
CEP290
ENST00000547926.7
TSL:1
n.1666delA
non_coding_transcript_exon
Exon 17 of 21ENSP00000448573.3F8VS29

Frequencies

GnomAD3 genomes
AF:
0.0000532
AC:
8
AN:
150322
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000733
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000741
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.00169
AC:
243
AN:
144116
AF XY:
0.00179
show subpopulations
Gnomad AFR exome
AF:
0.00235
Gnomad AMR exome
AF:
0.00106
Gnomad ASJ exome
AF:
0.000697
Gnomad EAS exome
AF:
0.00175
Gnomad FIN exome
AF:
0.00115
Gnomad NFE exome
AF:
0.00219
Gnomad OTH exome
AF:
0.000529
GnomAD4 exome
AF:
0.000173
AC:
234
AN:
1351878
Hom.:
0
Cov.:
31
AF XY:
0.000188
AC XY:
126
AN XY:
669516
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.000354
AC:
11
AN:
31060
American (AMR)
AF:
0.000476
AC:
17
AN:
35750
Ashkenazi Jewish (ASJ)
AF:
0.0000826
AC:
2
AN:
24200
East Asian (EAS)
AF:
0.000521
AC:
19
AN:
36462
South Asian (SAS)
AF:
0.000270
AC:
21
AN:
77742
European-Finnish (FIN)
AF:
0.000308
AC:
15
AN:
48656
Middle Eastern (MID)
AF:
0.000182
AC:
1
AN:
5506
European-Non Finnish (NFE)
AF:
0.000134
AC:
139
AN:
1036454
Other (OTH)
AF:
0.000161
AC:
9
AN:
56048
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.286
Heterozygous variant carriers
0
32
64
96
128
160
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000532
AC:
8
AN:
150422
Hom.:
0
Cov.:
32
AF XY:
0.0000408
AC XY:
3
AN XY:
73466
show subpopulations
African (AFR)
AF:
0.0000731
AC:
3
AN:
41032
American (AMR)
AF:
0.00
AC:
0
AN:
15048
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3444
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5128
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4754
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10236
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
290
European-Non Finnish (NFE)
AF:
0.0000741
AC:
5
AN:
67506
Other (OTH)
AF:
0.00
AC:
0
AN:
2074
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.425
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00195
Hom.:
0
Asia WGS
AF:
0.00145
AC:
5
AN:
3474

ClinVar

ClinVar submissions
Significance:Pathogenic
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
3
-
-
Joubert syndrome 5 (3)
3
-
-
not provided (3)
2
-
-
Leber congenital amaurosis (2)
2
-
-
Leber congenital amaurosis 10 (2)
2
-
-
Retinal dystrophy (2)
2
-
-
Senior-Loken syndrome 6;C1857780:Joubert syndrome 5;C1857821:Leber congenital amaurosis 10;C1970161:Meckel syndrome, type 4;C2673874:Bardet-Biedl syndrome 14 (2)
1
-
-
Bardet-Biedl syndrome 14 (1)
1
-
-
CEP290-related disorder (1)
1
-
-
Joubert syndrome 1 (1)
1
-
-
Meckel-Gruber syndrome;C0687120:Nephronophthisis;C5979921:Joubert syndrome (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
PhyloP100
2.8
Mutation Taster
=0/200
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs727503855; hg19: chr12-88512304; COSMIC: COSV58350055; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.